CEL-SCI Corp CVM:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/28/24 EDT
1.91UNCH (UNCH)
Volume
100,959
52 week range
1.04 - 3.23
Loading...
  • Open1.88
  • Day High1.91
  • Day Low1.81
  • Prev Close1.89
  • 52 Week High3.23
  • 52 Week High Date12/27/23
  • 52 Week Low1.04
  • 52 Week Low Date10/23/23

Key Stats

  • Market Cap103.10M
  • Shares Out53.98M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-29.78

KEY STATS

  • Open1.88
  • Day High1.91
  • Day Low1.81
  • Prev Close1.89
  • 52 Week High3.23
  • 52 Week High Date12/27/23
  • 52 Week Low1.04
  • 52 Week Low Date10/23/23
  • Market Cap103.10M
  • Shares Out53.98M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta1.29
  • YTD % Change-29.78

RATIOS/PROFITABILITY

  • EPS (TTM)-0.68
  • P/E (TTM)-2.80
  • Fwd P/E (NTM)-3.90
  • EBITDA (TTM)-26.337M
  • ROE (TTM)-158.25%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-118,011.00%
  • Debt To Equity (MRQ)89.29%

EVENTS

  • Earnings Date05/10/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CEL-SCI Corp

 

Profile

MORE
CEL-SCI Corporation is a clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system. The Company is focused on the development of product candidates and technologies, such as Multikine, an investigational immunotherapy under development for the potential treatment of certain head and neck cancers, and Ligand Epitope Antigen Presentation System (LEAPS), with several...
Geert Kersten Esq.
Chief Executive Officer, Chief Financial Officer, Treasurer, Director
Address
SUITE 802, 8229 BOONE BLVD .
Vienna, VA
22182
United States

Top Peers

SYMBOLLASTCHG%CHG
ANTX
AN2 Therapeutics Inc
3.25UNCHUNCH
ATHA
Athira Pharma Inc
2.74UNCHUNCH
BLRX
BioLine RX Ltd
1.12UNCHUNCH
VIGL
Vigil Neuroscience Inc
3.41UNCHUNCH
OTLK
Outlook Therapeutics Inc
11.94UNCHUNCH